0001209191-19-061057.txt : 20191217 0001209191-19-061057.hdr.sgml : 20191217 20191217210949 ACCESSION NUMBER: 0001209191-19-061057 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191213 FILED AS OF DATE: 20191217 DATE AS OF CHANGE: 20191217 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cui Jingrong Jean CENTRAL INDEX KEY: 0001772259 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38871 FILM NUMBER: 191291149 MAIL ADDRESS: STREET 1: C/O TURNING POINT THERAPEUTICS, INC. STREET 2: 10628 SCIENCE CENTER DR., STE. 225 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Turning Point Therapeutics, Inc. CENTRAL INDEX KEY: 0001595893 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 463826166 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10628 SCIENCE CENTER DRIVE, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-926-5251 MAIL ADDRESS: STREET 1: 10628 SCIENCE CENTER DRIVE, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: TP Therapeutics, Inc. DATE OF NAME CHANGE: 20181018 FORMER COMPANY: FORMER CONFORMED NAME: TP Therapeutics, INC DATE OF NAME CHANGE: 20140106 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-12-13 0 0001595893 Turning Point Therapeutics, Inc. TPTX 0001772259 Cui Jingrong Jean C/O TURNING POINT THERAPEUTICS, INC. 10628 SCIENCE CENTER DRIVE, STE. 200 SAN DIEGO CA 92121 1 1 0 0 Chief Scientific Officer Common Stock 1301298 D Common Stock 2019-12-13 4 S 0 7100 55.43 D 1019119 I By spouse Common Stock 2019-12-13 4 S 0 3800 56.17 D 1015319 I By spouse Common Stock 2019-12-13 4 S 0 600 56.95 D 1014719 I By spouse Common Stock 2019-12-16 4 S 0 600 55.45 D 1014119 I By spouse Common Stock 2019-12-16 4 S 0 2000 56.84 D 1012119 I By spouse Common Stock 2019-12-16 4 S 0 1300 57.59 D 1010819 I By spouse Common Stock 2019-12-16 4 S 0 5000 58.75 D 1005819 I By spouse Common Stock 2019-12-16 4 S 0 2400 59.76 D 1003419 I By spouse Common Stock 2019-12-16 4 S 0 200 60.43 D 1003219 I By spouse Common Stock 2019-12-17 4 S 0 3600 60.30 D 999619 I By spouse Common Stock 2019-12-17 4 S 0 8100 61.13 D 991519 I By spouse Common Stock 2019-12-17 4 S 0 6495 62.05 D 985024 I By spouse Common Stock 2019-12-17 4 S 0 305 62.71 D 984719 I By spouse Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li. The weighted average sale price for the transaction reported was $55.43, and the range of prices were between $54.775 and $55.77. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. The weighted average sale price for the transaction reported was $56.17, and the range of prices were between $55.825 and $56.78. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. The weighted average sale price for the transaction reported was $56.95, and the range of prices were between $56.84 and $57.04. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. The weighted average sale price for the transaction reported was $55.45, and the range of prices were between $55.05 and $55.98. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. The weighted average sale price for the transaction reported was $56.84, and the range of prices were between $56.20 and $57.19. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. The weighted average sale price for the transaction reported was $57.59, and the range of prices were between $57.22 and $57.90. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. The weighted average sale price for the transaction reported was $58.75, and the range of prices were between $58.305 and $59.265. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. The weighted average sale price for the transaction reported was $59.76, and the range of prices were between $59.41 and $60.34. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. The weighted average sale price for the transaction reported was $60.30, and the range of prices were between $59.66 and $60.60. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. The weighted average sale price for the transaction reported was $61.13, and the range of prices were between $60.68 and $61.68. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. The weighted average sale price for the transaction reported was $62.05, and the range of prices were between $61.70 and $62.70. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. The weighted average sale price for the transaction reported was $62.71, and the range of prices were between $62.71 and $62.74. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. /s/ Annette North, Attorney-in-Fact 2019-12-17